98 related articles for article (PubMed ID: 15043853)
1. Efficacy of long-term dietary restriction of total calories, fat, iron, and protein in patients with chronic hepatitis C virus.
Iwasa M; Iwata K; Kaito M; Ikoma J; Yamamoto M; Takeo M; Kuroda M; Fujita N; Kobayashi Y; Adachi Y
Nutrition; 2004 Apr; 20(4):368-71. PubMed ID: 15043853
[TBL] [Abstract][Full Text] [Related]
2. Dietary iron restriction improves aminotransferase levels in chronic hepatitis C patients.
Iwasa M; Kaito M; Ikoma J; Kobayashi Y; Tanaka Y; Higuchi K; Takeuchi K; Iwata K; Watanabe S; Adachi Y
Hepatogastroenterology; 2002; 49(44):529-31. PubMed ID: 11995488
[TBL] [Abstract][Full Text] [Related]
3. Additional effect of low iron diet on iron reduction therapy by phlebotomy for chronic hepatitis C.
Kimura F; Hayashi H; Yano M; Yoshioka K; Matsumura T; Fukuda T; Shigeto N; Yamahara S; Koushi F; Mishima Y; Yoshino T; Tanimoto M; Kimura I
Hepatogastroenterology; 2005; 52(62):563-6. PubMed ID: 15816478
[TBL] [Abstract][Full Text] [Related]
4. Restriction of dietary calories, fat and iron improves non-alcoholic fatty liver disease.
Yamamoto M; Iwasa M; Iwata K; Kaito M; Sugimoto R; Urawa N; Mifuji R; Konishi M; Kobayashi Y; Adachi Y
J Gastroenterol Hepatol; 2007 Apr; 22(4):498-503. PubMed ID: 17376040
[TBL] [Abstract][Full Text] [Related]
5. Effect of blood letting on serum aminotransferase levels of patients with chronic hepatitis C and iron overload.
Girelli CM; Mirata C; Casiraghi A
Recenti Prog Med; 1998 May; 89(5):241-4. PubMed ID: 9676130
[TBL] [Abstract][Full Text] [Related]
6. Normalization of elevated hepatic 8-hydroxy-2'-deoxyguanosine levels in chronic hepatitis C patients by phlebotomy and low iron diet.
Kato J; Kobune M; Nakamura T; Kuroiwa G; Takada K; Takimoto R; Sato Y; Fujikawa K; Takahashi M; Takayama T; Ikeda T; Niitsu Y
Cancer Res; 2001 Dec; 61(24):8697-702. PubMed ID: 11751387
[TBL] [Abstract][Full Text] [Related]
7. Continuous ambulatory peritoneal dialysis patients are unable to increase dietary intake to recommended levels.
Sutton D; Higgins B; Stevens JM
J Ren Nutr; 2007 Sep; 17(5):329-35. PubMed ID: 17720102
[TBL] [Abstract][Full Text] [Related]
8. Does dietary iron intake influence the iron status in hospitalised elderly patients?
Joosten E; Vanderelst B; Kerkhofs P; De Boeck S
J Nutr Health Aging; 1999; 3(1):8-10. PubMed ID: 10888477
[TBL] [Abstract][Full Text] [Related]
9. Effects of unsaturated fat dietary supplements on blood lipids, and on markers of malnutrition and inflammation in hemodialysis patients.
Ewers B; Riserus U; Marckmann P
J Ren Nutr; 2009 Sep; 19(5):401-11. PubMed ID: 19541503
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal changes in body weight and body composition among women previously treated for breast cancer consuming a high-vegetable, fruit and fiber, low-fat diet.
Thomson CA; Rock CL; Giuliano AR; Newton TR; Cui H; Reid PM; Green TL; Alberts DS;
Eur J Nutr; 2005 Feb; 44(1):18-25. PubMed ID: 15309460
[TBL] [Abstract][Full Text] [Related]
11. Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care--correlations with food intake, metabolism, exercise capacity, and hormones.
Fouladiun M; Körner U; Bosaeus I; Daneryd P; Hyltander A; Lundholm KG
Cancer; 2005 May; 103(10):2189-98. PubMed ID: 15822132
[TBL] [Abstract][Full Text] [Related]
12. Iron depletion and response to interferon in chronic hepatitis C.
Carlo C; Daniela P; Giancarlo C
Hepatogastroenterology; 2003; 50(53):1467-71. PubMed ID: 14571765
[TBL] [Abstract][Full Text] [Related]
13. Comparative study between occult hepatitis C virus infection and chronic hepatitis C.
Pardo M; López-Alcorocho JM; Rodríguez-Iñigo E; Castillo I; Carreño V
J Viral Hepat; 2007 Jan; 14(1):36-40. PubMed ID: 17212642
[TBL] [Abstract][Full Text] [Related]
14. Do protein and energy intakes explain long-term changes in body composition?
Stookey JD; Adair LS; Popkin BM
J Nutr Health Aging; 2005; 9(1):5-17. PubMed ID: 15750660
[TBL] [Abstract][Full Text] [Related]
15. A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C: a multicenter, prospective, randomized, controlled trial in Japan.
Yano M; Hayashi H; Yoshioka K; Kohgo Y; Saito H; Niitsu Y; Kato J; Iino S; Yotsuyanagi H; Kobayashi Y; Kawamura K; Kakumu S; Kaito M; Ikoma J; Wakusawa S; Okanoue T; Sumida Y; Kimura F; Kajiwara E; Sata M; Ogata K
J Gastroenterol; 2004 Jun; 39(6):570-4. PubMed ID: 15235875
[TBL] [Abstract][Full Text] [Related]
16. [Effect of iron depletion on long-term response to interferon in patients with chronic hepatitis C with increased plasma iron without accumulation of liver iron].
Cagnoni C; Corsini F; Pancotti D; Carrara G
Ann Ital Med Int; 2000; 15(2):132-8. PubMed ID: 10920503
[TBL] [Abstract][Full Text] [Related]
17. [Energy metabolism in patients with severe chronic viral hepatitis].
Meng QH; Yu HW; Feng YM; Li XM; Yu SQ; Li YX; Ni MM; Wang JH; Wang H; Liu Y
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(42):2982-5. PubMed ID: 18261330
[TBL] [Abstract][Full Text] [Related]
18. Relationship between serum ferritin, hepatic iron staining, diabetes mellitus and fibrosis progression in patients with chronic hepatitis C.
D'Souza RF; Feakins R; Mears L; Sabin CA; Foster GR
Aliment Pharmacol Ther; 2005 Mar; 21(5):519-24. PubMed ID: 15740534
[TBL] [Abstract][Full Text] [Related]
19. Effect of iron depletion on serum markers of fibrogenesis, oxidative stress and serum liver enzymes in chronic hepatitis C: results of a pilot study.
Alexander J; Tung BY; Croghan A; Kowdley KV
Liver Int; 2007 Mar; 27(2):268-73. PubMed ID: 17311623
[TBL] [Abstract][Full Text] [Related]
20. Is interferon-alpha therapy safe and effective for patients with chronic hepatitis C and inflammatory bowel disease? A case-control study.
Bargiggia S; Thorburn D; Anderloni A; Ardizzone S; Giorgi A; Bianchi Porro G; Parente F
Aliment Pharmacol Ther; 2005 Aug; 22(3):209-15. PubMed ID: 16091058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]